Walsh Rowan, Boyer Clark, LaCorte Jared, Parnell Vincent, Sison Cristina, Chowdhury Devyani, Ojamaa Kaie
Division of Pediatric Cardiology, Department of Pediatrics, Schneider Children's Hospital, New Hyde Park, New York, USA.
J Thorac Cardiovasc Surg. 2008 Jan;135(1):98-105. doi: 10.1016/j.jtcvs.2007.08.012.
The objectives of this study were to measure circulating N-terminal B-type natriuretic peptide levels in pediatric patients undergoing surgical repair of congenital heart lesions with left ventricular volume overload and to determine whether presurgical and immediate postoperative N-terminal B-type natriuretic peptide levels could predict patient outcomes after surgical intervention.
Thirty-eight children aged 1 to 36 months undergoing surgical repair of cardiac lesions with left ventricular volume overload were studied. Plasma N-terminal B-type natriuretic peptide levels were measured preoperatively and at 2, 12, 24, 48, and 72 hours after surgical intervention and were assessed for their predictive value of postoperative outcomes. Plasma N-terminal B-type natriuretic peptide levels were also measured in 34 similarly aged healthy children.
Patient preoperative N-terminal B-type natriuretic peptide levels were significantly higher than those of healthy control subjects (3085 +/- 4046 vs 105 +/- 78 pg/mL). Preoperative N-terminal B-type natriuretic peptide levels correlated with the complexity of surgical repair, as measured by cardiopulmonary bypass time (r = 0.529, P < .001), and with postoperative measures, including fractional inhaled oxygen requirements registered at 12 hours (r = 0.443, P = .005) and duration of mechanical ventilation (r = 0.445, P = .005). Plasma N-terminal B-type natriuretic peptide levels increased 5-fold within 12 hours after cardiopulmonary bypass (14,685 +/- 14,317 pg/mL). Multivariable regression analysis showed that the preoperative N-terminal B-type natriuretic peptide level was a significant predictor of duration of intensive care unit stay (P = .02) and that the peak postoperative N-terminal B-type natriuretic peptide level was a significant predictor of the intensity of overall medical management, as assessed by using the therapeutic intervention scoring system (P = .01).
Plasma N-terminal B-type natriuretic peptide levels measured preoperatively and postoperatively can be a prognostic indicator in the management of the pediatric patient after surgical intervention for congenital heart repair.
本研究的目的是测量接受先天性心脏病变左心室容量超负荷手术修复的儿科患者循环中的N末端B型利钠肽水平,并确定术前和术后即刻的N末端B型利钠肽水平是否能够预测手术干预后的患者预后。
对38名年龄在1至36个月、接受左心室容量超负荷心脏病变手术修复的儿童进行了研究。术前及手术干预后2、12、24、48和72小时测量血浆N末端B型利钠肽水平,并评估其对术后预后的预测价值。还对34名年龄相仿的健康儿童测量了血浆N末端B型利钠肽水平。
患者术前N末端B型利钠肽水平显著高于健康对照受试者(3085±4046 vs 105±78 pg/mL)。术前N末端B型利钠肽水平与手术修复的复杂性相关,通过体外循环时间衡量(r = 0.529,P <.001),也与术后指标相关,包括12小时时记录的吸入氧分数需求(r = 0.443,P =.005)和机械通气持续时间(r = 0.445,P =.005)。体外循环后12小时内血浆N末端B型利钠肽水平增加了5倍(14,685±14,317 pg/mL)。多变量回归分析显示,术前N末端B型利钠肽水平是重症监护病房住院时间的显著预测指标(P =.02),术后N末端B型利钠肽峰值水平是总体医疗管理强度的显著预测指标,通过治疗干预评分系统评估(P =.01)。
术前和术后测量的血浆N末端B型利钠肽水平可作为先天性心脏修复手术干预后儿科患者管理中的预后指标。